A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia (Q44280538)
Jump to navigation
Jump to search
scientific article published in April 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia |
scientific article published in April 2003 |
Statements
1 reference
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia (English)
1 reference
Astrid Gruber
1 reference
Magnus Björkholm
1 reference
Lorentz Brinch
1 reference
Stein Evensen
1 reference
Bengt Gustavsson
1 reference
Michael Hedenus
1 reference
Gunnar Juliusson
1 reference
Eva Löfvenberg
1 reference
Ingerid Nesthus
1 reference
Bengt Simonsson
1 reference
Malvin Sjo
1 reference
Leif Stenke
1 reference
Jon Magnus Tangen
1 reference
Ulf Tidefelt
1 reference
Ann-Mari Udén
1 reference
Christer Paul
1 reference
Jan Liliemark
1 reference
1 April 2003
1 reference
1 reference
27
1 reference
4
1 reference
323-328
1 reference
Identifiers
1 reference
1 reference